Fourth, a limitation of this study is the classification of all osteoporosis treatments as a single group, which prevents differentiation of effects among various drug classes, such as bisphosphonates, selective estrogen receptor modulators, and denosumab. The gene discussed is ESR1; the disease is osteoporosis.